GO Mobility

04/24/2026

https://newmobility.com/testing-two-new-seat-designs-that-will-let-you-fly-in-your-wheelchair/

John Morris visits the Aircraft Interiors Expo in Germany to test two new in-cabin wheelchair seating systems and find the answer to one important question: When will they be available on actual…

04/22/2026

https://newmobility.com/a-malpractice-case-against-parkingmd/

Writing or posting about disabled parking violations is like chumming the internet for outrage. As a power wheelchair user who depends on my side-entry rampvan, I get the outrage, but it bothers me…

03/24/2026

https://newmobility.com/learning-to-let-go-on-the-camino-de-santiago/https://newmobility.com/learning-to-let-go-on-the-camino-de-santiago/https://newmobility.com/learning-to-let-go-on-the-camino-de-santiago/https://newmobility.com/learning-to-let-go-on-the-camino-de-santiago/https://newmobility.com/learning-to-let-go-on-the-camino-de-santiago/https://newmobility.com/learning-to-let-go-on-the-camino-de-santiago/

New Mobility is the membership publication of United Spinal Association, whose mission is to empower people with spinal cord injuries and related disabilities to lead successful and fulfilling lives.

03/20/2026

https://vimeo.com/1174533491?share=copy&fl=sv&fe=ci

Using the subway in New York City as a wheelchair user is challenging. Less than half of the stations are accessible, which can mean a long push through the snow…

03/20/2026

https://newmobility.unitedspinal.org/NM_Travel_326/viewer/desktop/

02/28/2026

https://www.mccormick.northwestern.edu/news/articles/2026/02/paralysis-treatment-heals-lab-grown-human-spinal-cord-organoids/

A new therapy developed by Professor Samuel I. Stupp triggers neurite growth and reduces scarring in injured organoids.

02/25/2026

https://newmobility.com/wheelchair-users-favorite-home-workout-products/

New Mobility readers offers their favorite products — from strength to cardio and online services — for home workouts as a wheelchair user.

02/01/2026

https://spinalpedia.com/sci-grants-to-know-2026-edition/

One of the best ways to get the medical equipment, home modifications and other things you need after a spinal cord injury – but cannot afford – is to take advantage of the several spinal cord injury grants that are available across the US. We will be updating this list every year going forward....

01/16/2026

https://newmobility.com/funding-accessible-home-modifications/

Funding a home accessibility remodel or a new build of an accessible home is likely to be one of the biggest expenses you’ll ever have. But there are a variety of programs that can help ease the…

12/31/2025

https://nervgen.com/cto/

NVG-291 is a first-in-class drug candidate that is being evaluated in a Phase 1b/2a clinical trial. NervGen has initiated a Phase 1b/2a placebo-controlled proof-of-concept trial (NCT05965700) to evaluate the efficacy of NVG-291 in two separate cohorts of individuals with cervical spinal cord injury:...

12/31/2025

https://www.forbes.com/sites/the-prototype/2025/12/19/this-companys-drug-may-help-regenerate-injured-spinal-cords/?fbclid=IwY2xjawO_u0VleHRuA2FlbQIxMQBzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEeCvLDQpGDWIlBOknP_lwWHxHsAik8eY7s_eD9Xi6C_dNJ6jskukTiW9G1wDM_aem_gW8J2nSdwoaUx98Ke_e6DAhttps://www.forbes.com/sites/the-prototype/2025/12/19/this-companys-drug-may-help-regenerate-injured-spinal-cords/?fbclid=IwY2xjawO_u0VleHRuA2FlbQIxMQBzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEeCvLDQpGDWIlBOknP_lwWHxHsAik8eY7s_eD9Xi6C_dNJ6jskukTiW9G1wDM_aem_gW8J2nSdwoaUx98Ke_e6DA

In this week’s edition of The Prototype, we look at a drug to help spinal injuries, a crypto billionaire’s big space play, revitalizing aging immune systems and more.

12/20/2025

https://apnews.com/article/blue-origin-wheelchair-rocket-launch-e1b993bc7a66a1d587d94a0fb37aff8f

A paraplegic engineer has become the first wheelchair user in space, blasting off with Blue Origin. Severely injured in a mountain bike accident seven years ago, Michaela Benthaus rocketed away from West Texas on Saturday with Jeff Bezos' company.